Home>Topics>Stocks>Synopsys

Synopsys SNPS

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
    1. US SMALL/MIDCAPS-Stocks up on outlooks; coal miners down

      Headlines

      Thu, 24 May 2012

      NEW YORK, May 24 (Reuters) - Small- and midcapitalization stocks edged higher on Thursday, with shares of Synopsys Inc and other companies up after they raised their outlooks for the year.

    2. UPDATE 1- Synopsys reports strong qtrly sales, raises outlook

      Headlines

      Wed, 23 May 2012

      * Sees FY12 adj EPS $2.03-$2.07 vs prev. view $1.97-$2.03

    3. Synopsys ( SNPS ): FQ2 EPS of $0.53 misses by $0.02. Revenue of $432M (+9.9% Y/Y) beats by $15M. Shares -0.1% AH. (PR)

      Headlines

      Wed, 23 May 2012

      Synopsys ( SNPS ): FQ2 EPS of $0.53 misses by $0.02 . Revenue of $432M (+9.9% Y/Y) beats by $15M . Shares -0.1% AH. ( PR ) Post your comment!

    4. Synopsys Getting Hot After Magma Acquisition

      Commentary

      Wed, 23 May 2012

      Synopsys SNPS reported robust second-quarter results ..... our fair value estimate for the firm. Synopsys generated $432.5 million in revenues ..... quarter and $394 million a year ago. Synopsys benefited from strong demand for IP code

    5. Synopsys SNPS Q2 2012 Earnings Call Transcript

      Headlines

      Wed, 23 May 2012

      and gentlemen, thank you for standing by. Welcome to the Synopsys Earnings Conference Call for the Second Quarter Fiscal Year ..... the call today are Aart de Geus, Chairman and co-CEO of Synopsys and Brian Beattie, Chief Financial Officer. Click here for

    6. Notable earnings after Wednesday's close: [[HPQ]], [[NTAP]], [[P]], [[PVH]], [[ SNPS ]]

      Headlines

      Wed, 23 May 2012

      Notable earnings after Wednesday's close: HPQ , NTAP , P , PVH , SNPS , SPLK Post your comment!

    7. 3 Biotech Stocks On The Move

      Headlines

      Tue, 22 May 2012

      BREVAGen breast cancer test. BREVAGen offers unique preliminary DNA testing for the presence of single nucleotide polymorphisms ( SNPs ) which increase the likelihood of a woman developing breast cancer. The microcap company was up some 30% as of press time

    8. New Morningstar Analyst Report - Cadence Design Systems, Inc.

      Stock Reports

      Mon, 5 Mar 2012

      offerings competitive with rivals like Synopsys . Cadence Design is a leader in ..... losses. Cadence's competitor, Synopsys SNPS , was the chief beneficiary of the firm's struggles, and Synopsys now has an advantage in market

    9. Mentor Graphics Posts Results for Fourth-Quarter and Fiscal 2012

      Commentary

      Mon, 5 Mar 2012

      positioned in adjacent industries to outgrow the EDA market and has a first-mover advantage over its larger competitors, Synopsys SNPS and Cadence CDNS. Mentor increased its exposure to fluid dynamics systems with its December acquisition of Flowmaster

    10. New Morningstar Analyst Report - Mentor Graphics

      Stock Reports

      Mon, 5 Mar 2012

      major competitors, Cadence and Synopsys , have superior economies of scale ..... upfront, while both Cadence and Synopsys have moved to recognize revenues ..... Cadence Design Systems CDNS and Synopsys SNPS . Both firms have broader product

    « Prev12345Next »
    Content Partners